PROLOR Biotech (PBTH)
Add to Watchlists Create an AlertPBTH Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.3041 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -18.27M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 408.19M |
| Enterprise Value | 375.55M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 12.29 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -5.306M |
| Return on Equity | -68.01% |
PBTH News
- Prolor Biotech Buyout: Is The Opko Bear Case Now Dead? May 22
- PBTH July Options Begin Trading May 20
- PROLOR BIOTECH, INC. Financials May 17
- PROLOR BIOTECH, INC. Files SEC form 10-Q, Quarterly Report May 10
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy May 7
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breache... May 2
- Opko's Next Acquisition? May 2
- A Sweeter Deal On The Horizon For Prolor Biotech? May 1
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible B... Apr 29
- PROLOR BIOTECH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreem... Apr 29
PBTH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PROLOR Biotech is up 20.26% over the last year vs S&P 500 Total Return up 28.33%, Opko Health up 50.76%, and Array BioPharma up 63.44%.
PBTH Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these PBTH related companies
Pro Ratings for PBTH
Pro Report PDF for PBTH
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download PBTH Pro Report PDF
Pro Strategies Featuring PBTH
Did PROLOR Biotech make it into our Pro Portfolio Strategies?
PBTH Profile
Sector: Healthcare
Industry: Biotechnology
Other PBTH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PBTH | 6.41 | -0.02 | -0.31% | 408.19M |
